Randy Mojica-Flores

Mr. Randy Mojica-Flores

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2020 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
AAAllegra T. Aron
Allegra T. Aron
EGEmily C. Gentry
Emily C. Gentry
KMKerry L. McPhail
Kerry L. McPhail
LNLouis-Félix Nothias
Louis-Félix Nothias
MNMélissa Nothias-Esposito
Mélissa Nothias-Esposito
PDPieter C. Dorrestein
Pieter C. Dorrestein

Verified
Journal Article
Open access
PDF file
YGYisett González
Yisett González
RMRandy Mojica-Flores
Randy Mojica-Flores
DLDilan Moreno Labrador
Dilan Moreno Labrador
Luis Cubilla-RiosLuis Cubilla-Rios
Luis Cubilla-Rios
Rao KosagisharafRao Kosagisharaf
Rao Kosagisharaf
JLJohant Lakey-Beitia
Johant Lakey-Beitia
Herein, we describe the synthesis and evaluation of anti-inflammatory activities of new curcumin derivatives. The thirteen curcumin derivatives were synthesized by Steglich esterification on one or both of the phenolic rings of curcumin with the aim of providing improved anti-inflammatory activity. Monofunctionalized compounds showed better bioactivity than the difunctionalized derivatives in terms of inhibiting IL-6 production, and known compound 2 presented the highest activity. Additionally, this compound showed strong activity against PGE2. Structure–activity relationship studies were carried out for both IL-6 and PGE2, and it was found that the activity of this series of compounds increases when a free hydroxyl group or aromatic ligands are present on the curcumin ring and a linker moiety is absent. Compound 2 remained the highest activity in modulating IL-6 production and showed strong activity against PGE2 synthesis.

26 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YGYisett González
Yisett González
RMRandy Mojica-Flores
Randy Mojica-Flores
DLDilan Moreno Labrador
Dilan Moreno Labrador
MPMarisín Pecchio
Marisín Pecchio
Rao KosagisharafRao Kosagisharaf
Rao Kosagisharaf
JLJohant Lakey-Beitia
Johant Lakey-Beitia
Tetrahydrocurcumin, the most abundant curcumin transformation product in biological systems, can potentially be a new alternative therapeutic agent with improved anti-inflammatory activity and higher bioavailability than curcumin. In this article, we describe the synthesis and evaluation of the anti-inflammatory activities of tetrahydrocurcumin derivatives. Eleven tetrahydrocurcumin derivatives were synthesized via Steglich esterification on both sides of the phenolic rings of tetrahydrocurcumin with the aim of improving the anti-inflammatory activity of this compound. We showed that tetrahydrocurcumin (2) inhibited TNF-α and IL-6 production but not PGE2 production. Three tetrahydrocurcumin derivatives inhibited TNF-α production, five inhibited IL-6 production, and three inhibited PGE2 production. The structure–activity relationship analysis suggested that two factors could contribute to the biological activities of these compounds: the presence or absence of planarity and their structural differences. Among the tetrahydrocurcumin derivatives, cyclic compound 13 was the most active in terms of TNF-α production, showing even better activity than tetrahydrocurcumin. Acyclic compound 11 was the most effective in terms of IL-6 production and retained the same effect as tetrahydrocurcumin. Moreover, acyclic compound 12 was the most active in terms of PGE2 production, displaying better inhibition than tetrahydrocurcumin. A 3D-QSAR analysis suggested that the anti-inflammatory activities of tetrahydrocurcumin derivatives could be increased by adding bulky groups at the ends of compounds 2, 11, and 12.

25 October 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
Cristopher A. Boya P.Cristopher A. Boya P.
Cristopher A. Boya P.
Candelario RodriguezCandelario Rodriguez
Candelario Rodriguez
RMRandy Mojica-Flores
Randy Mojica-Flores
JGJean Carlo Urrutia Guevara
Jean Carlo Urrutia Guevara
VCVíctor Cantilo-Diaz
Víctor Cantilo-Diaz
MGMarcelino Gutiérrez
Marcelino Gutiérrez
Background: Collectively, leishmaniasis and Chagas disease cause approximately 8 million cases and more than 40,000 deaths annually, mostly in tropical and subtropical regions. The current drugs used to treat these diseases have limitations and many undesirable side effects; hence, new drugs with better clinical profiles are needed. Fungal endophytes associated with plants are known to produce a wide array of bioactive secondary metabolites, including antiprotozoal compounds. In this study, we analyzed endophytic fungal isolates associated with Theobroma cacao and Coffea arabica crop plants, which yielded extracts with antitrypanosomatid activity. Methods: Crude extracts were subjected to bioassay-guided isolation by HPLC, followed by spectrometric and spectroscopic analyses via mass spectrometry (MS) and nuclear magnetic resonance (NMR), Results: Compounds 1–9 were isolated and displayed novel antitrypanosomal and antileishmanial activities ranging from 0.92 to 32 μM. Tandem liquid chromatography–mass spectrometry (LC–MS) analysis of the organic extracts from different strains via the feature-based Global Natural Products Social (GNPS) molecular networking platform allowed us to dereplicate a series of metabolites (10–23) in the extracts. Molecular docking simulations of the active compounds, using the 3-mercaptopyruvate sulfurtransferase protein from L. donovani (Ld3MST) and the cruzipain enzyme from T. cruzi as putative molecular targets, allowed us to suggest possible mechanisms for the action of these compounds. Conclusions: The isolation of these antiprotozoal compounds confirms that crop plants like coffee and cacao harbor populations of endophytes with biomedical potential that confer added value to these crops.